Relief Therapeutics Holding AG (RLFTF)

[tryn2]

Well done!!!
From the paper:

"At 28 days, a Aviptadil patients treated with HFNC were 35% - 46% more likely to recover, return home, and survive to 28 days compared to placebo-treated patients, with a trend level of significance. Aviptadil patients additionally demonstrated a highly statistically significant and clinically dramatic ten day reduction in hospitalization time. Should similar findings be observed at 60 days, Emergency Use Authorization will be sought."

Guess it doesn't hurt to state this important finding in multiple places so board members don't miss it...(-: